OrbiMed — Full Portfolio

GENEWIZ provides sequencing, synthesis, and molecular biology services for research, clinical, and therapeutic applications, serving academic institutions, biotech companies, and pharmaceutical organizations.

BiotechDeep TechHealthtechMedical Devices

ALAmy Liao, PhD(Founder)in

Co-investorsAMAmpersand

A research-intensive biopharmaceutical company that develops medicines and vaccines.

BiotechHealthtechSouth San Francisco, US

Luke Nathaniel Walker(Executive Officer)JEJulie Eastland(Executive Officer, Director)in

BoardRonald Hunt(Director)Mark Chin(Director)Alan Colowick(Director)Jonathan Drachman(Director)

Co-investorsK2K2 HealthVenturesRIRidgeback CapitalTATaiho Ventures, LLCARArix BioscienceLILilly Asia VenturesMPMPM BioImpact+1 more

HiRO is a full-service global contract research organization (CRO) that manages clinical trials for biotech companies, integrating regulatory strategy, clinical data science, clinical operations, medical monitoring, and quality into a single execution model.

AI & Machine LearningBiotechDigital HealthHealthtech

CCCrista Casey(Chief Operations Officer)in

Helicore Bio develops long-acting antibody-peptide conjugate therapies for obesity and cardiometabolic disease, using proprietary GLP-1R agonist and amylin receptor agonist peptide libraries combined with a GIP ligand-binding antibody backbone.

BiotechHealthtechSouthbury, US

KRKevin Russ(Chief Executive Officer)inPDPeter DiLaura(Chief Executive Officer and Board Director)inWaters Kellogg(Director)Lucas B. Turner(Director)Joshua Dotson(Director)Holger Koehler(Director)

Co-investorsLOLongitude CapitalWEWellington ManagementVEVersant Ventures

Iambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors.

AI & Machine LearningBiotechDeep TechSan Diego, US

TMTom Miller(Founder)inFred Manby(Founder)inCZChao Zhang(Executive Officer)inTabbert Teng(Executive Officer)NJNeil Josephson(Chief Medical Officer)inPOPete Olson(Chief Scientific Officer)in

Co-investorsASAscenta CapitalABAbingworthCACatalio Capital ManagementALAlumni VenturesCACatalio Capital Management, LPCOCoatue Management+7 more

ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases.

BiotechHealthtechSan Diego, US

Co-investorsATAtlas Venture

Intellia is a consulting firm that helps public sector organizations transform their services by integrating digital solutions, reducing costs, and managing workforce transitions.

GovTech

Co-investorsFAFatima Gobi VenturesGOGobi PartnersRIRidgeback Capital

InventisBio is a China-based drug discovery company developing patent-protected small-molecule targeted therapies for oncology and metabolic diseases.

BiotechHealthtechShanghai, CN

Xing Dai(Founder)inYWYaolin Wang(Founder)in

Co-investorsLALAVLILilly Asia VenturesQIQiming Venture Partners

One of India's leading fertility chains offering assisted reproductive treatments.

Arun Muthuvel Veluswamyin

Janux Therapeutics is a clinical-stage biotech company developing precision-engineered immunotherapies for the treatment of cancer and autoimmune diseases.

BiotechDeep TechHealthtechMedical DevicesLa Jolla, US

DCDavid Campbell, Ph.D.(Executive Officer, Director)inTRTighe Reardon(Executive Officer)

BoardJay Lichter, Ph.D.(Director)Jake Simson, Ph.D.(Director)PTPeter Thompson, M.D.(Director)inStefan Heller(Director)

Co-investorsAVAvalon BioVenturesSASamsara BioCapital

锦欣康养 is a subsidiary of Jinxin Medical Group that operates elderly care services combining medical treatment and senior living, including institutional care, home and community care, geriatric medicine, rehabilitation, and nursing.

HealthtechLongevityWellness & FitnessChengdu, CN

Kapiva is an Ayurvedic wellness brand that makes natural and organic nutrition products, such as amla, wheatgrass, and aloe vera juices, based on traditional Ayurvedic practices combined with modern science.

ConsumerDirect to ConsumerWellness & Fitness

Ameve

Co-investorsJEJetty VenturesSHSharrp VenturesTRTrifecta Capital AdvisorsVEVertex Ventures Sea Management Pte. Ltd.3O3one4 CapitalVEVertex Growth

Kartos Therapeutics develops targeted small-molecule therapeutics aimed at treating patients with solid tumors and hematological cancers.

BiotechHealthtech

Co-investorsSRSR One Capital Management

Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis.

HardwareHealthtechMedical DevicesOakland, US

ADAnand Doraiswamy(Executive Officer, Director)in

BoardJBJosh Baltzell(Director)inJGJan Garfinkle(Director)in

Co-investorsAPAphelion CapitalARArboretum VenturesSCScientific Health DevelopmentZÜZühlke VenturesASAsahi Kasei Corporate VenturesCACadence Healthcare Ventures

Kumquat Biosciences is a biotech company developing small-molecule cancer therapeutics, combining drug discovery and clinical expertise to advance new oncology treatments.

BiotechSan Diego, US

Yi Liu(Executive Officer, Director)inYLYi Liu, Ph.D.(CEO)Lynn Yang(Director)

BoardCGCarl Gordon(Director)in

Co-investorsECEcoR1 CapitalRORoche Venture Fund

Develops innovative therapies for cancer and liver diseases.

Co-investorsHBHB VenturesINInfinity Capital

Laxmi Dental Limited is an India-based, vertically integrated dental products company producing custom crowns and bridges, clear aligners and related aligner solutions, and paediatric dental products.

Advanced ManufacturingHealthtechMedical Devices

Co-investorsGOGoldman SachsMAMax Life InsuranceNONomura

Leal 360 is a retail-focused customer platform for LATAM that combines a CDP, campaign automation, loyalty programs, and NPS with an AI decision engine, connecting to a business's POS to turn purchase data into personalized marketing and loyalty actions.

AI & Machine LearningMarketing TechRetail Tech

Camilo Martínez(Founder)Florence Frech(Founder)

Co-investorsASAspira CapitalAXAxon Partners GroupCACapria VenturesFUFuel Venture CapitalININCA VENTURESLELEAP Global Partners+8 more

Leal Therapeutics is a company focused on CNS (central nervous system) disorders, drawing on academic and drug-development experience in neurology and neurodegenerative disease.

BiotechHealthtechMedical DevicesWorcester, US

AAAsa Abeliovich(CEO & Founder, Director)

Co-investorsSVSV Health InvestorsABAbbVieDEDementia Discovery FundNENewpath Partners

Lexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases.

BiotechDigital HealthHealthtechNew York City, US

Ronald Crystal, MD(Founder & Chief Scientific Adviser)RNR. Nolan Townsend(Chief Executive Officer)inNBNarinder Bhalla, MD(Chief Medical Officer)José Manuel Otero, PhD(Chief Operating Officer)Louis Tamayo(Chief Financial Officer)in

Co-investorsLOLongitude Capital

LifeCell Diagnostics provides preventive health checkups and lab tests, including full-body checks, women's wellness packages, allergy panels, and organ-specific tests, with at-home sample collection and digital report delivery.

BiotechConsumerDigital HealthHealthtechMedical DevicesChennai, IN

AKAbhaya Kumar Jain(Chairman)MAMayur Abhaya Jain(Managing Director)SSSumanth Sarangapani(CEO)in

LogicBio is a biotechnology company focused on research and development of treatments for rare diseases, investigating new targets, modalities, and technologies for patients and their families worldwide.

BiotechHealthtechCambridge, US

Leszek Lisowski(Executive Officer, Director)Mark A. Kay(Director)Adi Barzel(Executive Officer, Director)

BoardECErez Chimovits(Director)in

Co-investorsANAndera PartnersPOPontifax Venture CapitalSBSBI JI Innovation Advisory Ltd.ARArix Bioscience

Lomond Therapeutics is a small molecule oncology drug discovery company developing differentiated therapies that target biological pathways with resistant mutations and escape mechanisms in hematologic malignancies.

BiotechHealthtech

IDIain Dukes(CEO)inNikolay Savchuk(COO)ABAmy Burd(CSO)Brian Ledwith(Chief Development Officer)Fraser Pickersgill(Head CMC)John Byrd(Interim Chief Medical Officer)

Loxo develops SAE Level 4 autonomous driving technology, marketed as a vehicle-agnostic "Digital Driver" for urban delivery operations.

AI & Machine LearningLogistics & Supply ChainMobility & Transportation

Co-investorsSESerpentine VenturesAIAisling Capital

BiotechStamford, US

JHJoshua H. Bilenker(Executive Officer, Director)

BoardDov Goldstein(Director)James Barrett(Director)David Bonita(Director)SESteven Elms(Director)inAvi Naider(Director)

Co-investorsAIAisling CapitalNENew Enterprise Associates (NEA)

Lupeng Pharmaceutical develops next-generation small-molecule targeted drugs for malignant tumors and autoimmune diseases, focusing on hematologic cancer targets such as BTK, Bcl-2, and Bcl-xL, with multi-center clinical development and commercialization in international and Chinese markets.

BiotechHealthtech

周正清(首席财务官 (CFO))Stephen Anthony(首席医学官 (Chief Medical Officer))

Co-investorsLALAVLILilly Asia Ventures

Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation.

BiotechHealthtechSouth San Francisco, US

CBCarolyn Bertozzi(Lycia founder and Professor of Chemistry, Stanford University)inAWAetna Wun Trombley(President and CEO)inABAmy Bachrodt(Chief Financial Officer)inCLChin Lee(Chief Medical Officer)inSSSteve Staben(Chief Scientific Officer)inSTSofia Touami(Chief Business Officer)in

Co-investorsREREDMILEVEVersant VenturesHBHBM Healthcare InvestmentsHBHBM PartnersBABAM ElevateFRFranklin Templeton+5 more

MagentaMed develops the Elevate percutaneous Left Ventricular Assist Device (pLVAD), a low-profile, high-flow arterial pump for temporary mechanical circulatory support.

HardwareHealthtechMedical DevicesKadima, IL

Yosi Tuval(MSc – Co-Founder & CTO)ESEhud Schwammenthal(MD, PhD – Co-Founder & CMO)inDIDavid Israeli(MD, MBA – Chairman & CEO)in

Co-investorsALALIVE Israel HealthTech FundFRFresenius Medical Care VenturesNENew Enterprise Associates (NEA)RARA CapitalVIViking GlobalPIPitango

Marksans Pharma is an Indian pharmaceutical company that researches, manufactures, and markets finished dosage pharmaceutical formulations.

BiotechHealthtech

MBX Biosciences is a clinical-stage biopharmaceutical company developing peptide therapeutics for endocrine and metabolic diseases.

BiotechHealthtechCarmel, US

RDRichard DiMarchi(Founder)Peter Kent Hawryluk(Executive Officer, Director)Timothy Knickerbocker(Executive Officer, Director)inSHSteve Hoerter(Chairman & Chief Executive Officer)inSASalomon Azoulay(Chief Medical Officer)inKBKaren Basbaum(Chief Business Officer)in

Co-investorsFRFrazier Life SciencesNONorwest Venture PartnersIUIU VenturesNENew Enterprise Associates (NEA)WEWellington ManagementFRFrazier Healthcare Partners

MDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases.

BiotechDigital HealthHealthtechMedical DevicesHerstal, US

JBJohn Bellano(Chief Commercial Officer of the Issuer.)inRKRon Kalfus(Chief Financial Officer of the Issuer.)inJSJoseph Sollee(Executive Officer)WVWim Van Criekinge(Chief Scientific Officer)inMichael McGarrity(Chief Executive Officer & Executive Director)Christian Sollee(Executive Vice President of Corporate Development and General Counsel)

Co-investorsANAndera Partners

MedPharm is a contract development and manufacturing organization (CDMO) focused on topical, transdermal, and transepithelial drug products, supporting formulation development, in vitro testing, and GMP manufacturing from early development through commercial supply.

Advanced ManufacturingBiotechHealthtechMedical DevicesGuildford, GB

Co-investorsAMAmpersand

MEMEBOX (미미박스/MBX) is a global beauty company that builds and sells K-beauty brands and products, marketed to consumers in over 40 countries.

ConsumerDirect to ConsumerE-commerceSeoul, KR

H(Hyungseok (Dino) Ha(Founder)inHHHyungseok Ha(CEO / Representative)inDino Ha(Founder)

Co-investorsCLClick VenturesCOCota CapitalCOCowboy VenturesFUFundersClubMOMontage CapitalPRPROOF+14 more

RarePath is a biotech platform that creates pathways for scientists to develop cures for rare and ultra-rare diseases by partnering with academic researchers, biotech firms, and patient foundations to fund, license, and commercialize therapies.

BiotechSan Francisco, US

Lalarukh Haris Shaikh(Founder)in

Co-investors5A5AM Ventures8V8VCWIWingNVNVIDIA

Mirador provides digital lending platform software for financial institutions, credit unions, and banks to streamline online loan applications.

Cloud ComputingEnterprise SoftwareFintechSaaS

Co-investorsCOCore Venture CapitalNYNycaNYNyca PartnersARARCH Venture PartnersFIFidelity InvestmentsINInvus+3 more

Mirador discovers and develops precision medicines for immune-mediated and immuno-fibrotic diseases using a target-patient matching approach.

AI & Machine LearningHealthtechMedical DevicesSan Diego, US

MCMark C. McKenna(Executive Officer, Director)inJoseph Papa(Director)Scott Glenn(Director)Vika Brough(Executive Officer)Timothy K. Andrews(Executive Officer)Mark McKenna(Founder)

Co-investorsAQAquiline Technology GrowthARARCH Venture PartnersSASanofi VenturesINInvusPOPoint72VEVenrock Healthcare Capital Partners

Mondego Bio develops PTPN2 (protein tyrosine phosphatase non-receptor type 2) inhibitors as immuno-oncology therapies, aiming to enhance IFNγ signaling to make tumor cells more susceptible to immune attack.

BiotechHealthtechCantanhede, PT

Myriad Genetics is a genetic testing and precision medicine company that delivers molecular diagnostic test results across hereditary cancer risk, reproductive health, oncology, urology, and mental health.

AI & Machine LearningBiotechDigital HealthHealthtechSalt Lake City, US

Richard Marsh(Executive Officer)Lawrence C. Best(Director)W. Lloyd Sanders(Executive Officer)Dennis Langer(Director)Mark C. Capone(Executive Officer, Director)S. Louise Phanstiel(Director)

Co-investorsHAHack VCTETen VC

Nanotronics develops technology for manufacturing, positioning customers to gain an edge in production processes.

Advanced ManufacturingAI & Machine LearningDeep TechHardwareSemiconductorsBrooklyn, US

JPJohn Putman(Founder)inMPMatthew Putman(Founder)in

BoardPTPeter Thiel(Director)in

Co-investorsFOFounders FundMEMetaplanetINInvestment Corporation of Dubai (ICD)MAMana Ventures

Neurelis is a neuroscience-based biopharmaceutical company that develops treatments for people living with neurological conditions such as epilepsy.

BiotechHealthtechMedical DevicesEncinitas, US

CCCraig Chambliss(Founder)in

BoardDavid F. Hale(Director)Cam Garner(Director)Yong Zhang(Director)KLKevin Li(Director)in

Co-investorsHBHBM Healthcare InvestmentsHBHBM PartnersLYLYZZ Capital

Shanghai NewMed Medical is a Chinese medical device company founded in 2015 that develops, manufactures, and sells transcatheter artificial heart valves and interventional ventricular assist systems.

BiotechHardwareHealthtechMedical DevicesShanghai, CN

Co-investorsLYLYZZ Capital

Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection.

BiotechDigital HealthHealthtechMedical Devices

EFEli Frydman(President EMEA)

Co-investorsGEGefen CapitalRARA CapitalAUAurum Ventures MKIBLBlackRockLILilly Asia VenturesLYLYFE Capital+1 more

Nucleus RadioPharma develops and manufactures radiopharmaceutical products, with production facilities capable of scaling to hundreds of thousands of doses per year.

Advanced ManufacturingBiotechHealthtechPalo Alto, US

Stephen M. Hahn(Chief Executive Officer & Board Member)Tyrell Rivers(Director)Mary Kate Wold(Director)Michael Rossi(Director)Norman Sharpless(Director)Chris McDonald(Director)

Co-investorsECEclipseECEclipse Ventures

Odyssey Therapeutics develops small molecule and protein therapeutics targeting upstream signaling nodes and innate immune system mechanisms to prevent pathological inflammation.

BiotechMedical DevicesCambridge, US

GDGary D Glick(Executive Officer, Director)inGary D. Glick(Founder)

BoardJCJill Carroll(Director)inCGCarl Gordon(Director)inValerie Odegard(Director)Jeffrey Leiden(Director)

Co-investorsACActivant CapitalASAscenta CapitalBABalderton CapitalCACatalio Capital Management, LPFOForesite CapitalGLGlobal BioAccess Fund+9 more

AI-powered pathology for improved patient outcomes

Boston, US

ABANDREW BECK(Executive Officer, Director)inAKADITYA KHOSLA(Executive Officer, Director)Aditya Khosla(Founder)Andy Beck(Founder)

BoardMICHELLE DIPP(Director)SLSTANLEY LAPIDUS(Director)in

Co-investors8V8VCBIBIOSPRING PARTNERSFAFairhaven Capital PartnersGEGeneral CatalystHIHighsage VenturesMEMerck Global Health Innovation Fund+6 more

Pathalys Pharma is a biotechnology company developing and improving therapeutic treatments for patients with chronic kidney disease.

BiotechHealthtechResearch Triangle Park, US

BSBT Slingsby(Co-Founder & Executive Chairman)in

Co-investorsABAbingworthCACatalys PacificSASamsara BioCapitalKBKB Investment

Pee Safe is a personal hygiene and menstrual care brand offering products such as toilet seat sanitizer sprays, sanitary pads in multiple absorbency levels, menstrual cups, period panties, panty liners, disposable bags, intimate wash, intimate wipes, and period pain relief products.

Direct to ConsumerFemTechWellness & Fitness

VBVikas Bagaria(Founder)inSBSrijana Bagaria(Founder)inRKRithish Kumar(Founder)in

Co-investorsALAlkemi Growth CapitalWEWe Founder Circle Global Angels Fund

BiotechBoston, US

Dr. Richard Peters(Director)Belinda Termeer(Director)DADr. Alan E. Walts(Director)inDr. Gerhard Wagner(Director)SASun Altbach(Executive Officer, Director)in

Co-investorsADAdvent Life SciencesLULumira Ventures

Pinnacle Medicines develops oral peptide-based therapies designed to deliver antibody-like efficacy in pill form for patients with chronic diseases.

BiotechDigital HealthDoylestown, US

CSChengzao Sun(Founder)inSandeep Somani(Founder)in

Co-investorsFOForesite CapitalQUQuan CapitalRARA CapitalLALAVVEVenrock

HealthtechSan Francisco, US

Matthew F. Krummel, Ph.D.(Director)SPSteven P. James(Executive Officer, Director, Promoter)inLeon Chen, Ph.D.(Director)CGCarol Gallagher(Director)inJoshua Resnick, M.D.(Director)

BoardMichael Powell(Director)

Co-investorsMIMission Bay CapitalMIMission BiocapitalNENew Enterprise Associates (NEA)OUOUP (Osage University Partners)SOSofinnova VenturesSOSofinnova Venture Partners

PMV Pharma develops precision oncology therapies that target and structurally correct mutated p53 proteins to restore their tumor-suppressing function.

BiotechHealthtechCranbury, US

DHDavid H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Director)

BoardPTPeter Thompson(Director)inSteve Winick(Director)Arnold Oronsky(Director)

Co-investorsAVAvoro Capital AdvisorsNENextech InvestOUOUP (Osage University Partners)RARA CapitalVIViking GlobalWEWellington Management+1 more

<UNKNOWN>

San Francisco, US

BLBastian Lehman(Founder & CEO)SSSam Street(Founder)inSPSean Plaice(Founder)inBastian Lehmann(Founder)

BoardLee Fixel(Director)SBScott Banister(Director)in

Co-investorsANAngelPadBRBrighter CapitalCRCraft VenturesCRCrosslink CapitalENEntrée CapitalEXExpansion Venture Capital+61 more

Practice Fusion provides a cloud-based electronic health record (EHR) platform with integrated medical billing services and e-prescribing for independent medical practices.

Digital HealthHealthtechSaaSSan Francisco, US

RHRyan Howard(Executive Officer, Director)in

BoardMark Goines(Director)BSBeth Seidenberg(Director)inMichael Harden(Director)Cora Tellez(Director)

Co-investorsBABand of AngelsCACanvas VenturesLOLongitude CapitalARArtis VenturesDEDeerfield Management CompanyFEFelicis Ventures+6 more

BiotechSouth San Francisco, US

MBMARTIN BABLER(Executive Officer, Director)in

BoardPTPETER THOMPSON(Director)inSASRINIVAS AKKARAJU(Director)MDMICHAEL DYBBS(Director)inSIMEON GEORGE(Director)LEWIS J. SHUSTER(Director)

Co-investorsACAccess BiotechnologyMIMission BiocapitalSOSofinnova VenturesSRSR One Capital ManagementMIMission Bay CapitalNENew Leaf Venture Partners+1 more

Prolynx develops ultra-long-acting therapeutics for obesity and metabolic diseases such as type 2 diabetes, using a hydrogel-based microsphere platform with tunable release linker chemistry to control drug release over extended dosing intervals.

BiotechDeep Tech

GAGary Ashley(Co-Founder)inDSDaniel Santi(Co-Founder)inCBChris Boulton(CEO)inSimon Harnest(Chief Financial Officer)inAMAmer Mirza(Chief Scientific Officer)inCWChristian Weyer(Chief Medical Officer)in

Co-investorsMOMonograph Capital Partners

Propeller Bio discovers and develops biologic therapeutics that target multiple disease-driving pathways to achieve synergistic effects, aimed at patients with unmet medical needs.

BiotechSan Francisco Bay Area, US

DWDavid W. Shen(Founder)in

Co-investorsFOForesite CapitalBLBlackbird VenturesMCMcKesson Ventures

ProVerum is a venture-backed medical device startup developing minimally invasive technologies to treat benign prostatic hyperplasia (BPH).

HardwareHealthtechMedical DevicesDublin, IE

Dr Conor Harkin(Founder)inRNRíona Ní Ghriallais(Founder)in

Co-investorsATAtlantic Bridge VenturesIRIreland Strategic Investment FundLILightstone VenturesMVMVM Life Science Partners

Radius is a pharmaceutical company that provides funding through Investigator Initiated Study grants and independent Medical Education grants supporting clinical research and continuing medical education for healthcare professionals in therapeutic areas related to its products.

BiotechHealthtech

Developing safe, long-lasting gene therapy treatments in a redosable, non-viral format.

Louis Breton(Founder)in

Co-investorsHEHealthCapFOForbion

RAPT Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that target the immune system to treat inflammatory and immunologic diseases.

BiotechHealthtech

Co-investorsFOForesite CapitalFRFrazier Life SciencesGVGV (Google Ventures)KLKleiner PerkinsMEMedicxiSOSolasta Ventures+1 more

A biopharmaceutical company developing therapies for neurology, immunology, and rare diseases.

BiotechHealthtech

Co-investorsFOForesite CapitalTTTTM

ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs.

AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US

Dr. Daniel J. SiegwartArthur E Johnson(Executive Officer, Director)

Co-investorsAJAju IB InvestmentECEcoR1 CapitalEVEvolution VC PartnersMPMPM BioImpactOUOUP (Osage University Partners)PFPfizer Venture Investments+6 more

Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD).

BiotechHealthtechBerkeley, US

Jeremy Reiter(Scientific Co-Founder)Markus Delling(Scientific Co-Founder)TGThomas Gustafson(Executive Officer)inECEmily Conley(Executive Officer, Director)in

BoardECEvan Caplan(Director)inCharlotte McKee(Director)

Co-investors5A5AM VenturesATAtlas VentureQIQiming Venture PartnersQIQiming Venture Partners USA

Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods.

ConsumerMedia & Entertainment

Co-investorsANAndera PartnersBRBrace PharmaNENew Leaf Venture PartnersWEWellcome Trust

This page is a news post from Azafaros, a biopharmaceutical company developing disease-modifying therapeutics for lysosomal storage disorders with a focus on neurological symptoms.

Biotech

Co-investorsCDCDP Venture CapitalIRIreland Strategic Investment FundADAdams Street PartnersGEGenesys CapitalHEHealthCapPIPivotal Life Sciences+1 more

Sidewinder Therapeutics is a biotechnology company focused on oncology drug discovery and development, working on next-generation cancer treatments.

BiotechHealthtechMedical DevicesSan Diego, US

EMEric Murphy(Chief Executive Officer, Co-Founder, & Director)in

Co-investorsASAstellas Venture Management LLCDCDCVC (Data Collective)DCDCVC BioFRFrazier Life SciencesLOLongwood FundNONovartis Venture Fund+2 more

Sikka provides integrated software for dental practices that consolidates scheduling, insurance, payments, reviews, and reporting in a single platform while automating administrative workflows like recalls and claim management.

Enterprise SoftwareHealthtechSaaS

Co-investorsMOMoneta VenturesSISierra VenturesARAramco Ventures

Sikka Soft offers software for dental and medical practices that connects scheduling, insurance, payments, reviews, and reporting, and automates front-office follow-up on recalls, balances, and claims.

Digital HealthHealthtechSaaS

BiotechDigital HealthMedical DevicesSeattle, US

PAPeter A. Thompson(Executive Officer, Director)in

Co-investorsECEcoR1 CapitalPOPontifax Venture CapitalRARA CapitalUSUS Venture PartnersALAlexandriaNENextech Invest

Sitala Bio develops treatments targeting harmful inflammation for neurodegenerative and inflammatory diseases.

BiotechHealthtechCambridge, GB

SpectronRx develops and manufactures theranostic and diagnostic molecular isotope products (radiopharmaceuticals), operating research and production facilities including cyclotron sites.

Advanced ManufacturingBiotechHealthtechMedical DevicesDanbury, US

JZJohn Zehner(CEO)inAnwer Rizvi(President)in

StairMed develops invasive brain-computer interface technology, including ultra-flexible micro-nano electrodes, an implantation-assist device, an implantation surgical robot, and a high-throughput neural signal acquisition system.

Deep TechHealthtechMedical Devices

Co-investorsSOSource Code Capital

Star Therapeutics develops treatments aimed at addressing real-world patient needs.

BiotechSouth San Francisco, US

ARAdam Rosenthal(Founder & CEO)inNSNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)SRScott Robertson(Executive Officer)inGary Patou(Executive Officer)in

Co-investorsFRFrazier Life SciencesRARA CapitalSASanofi VenturesSOSofinnova VenturesVIViking GlobalAGAgent Capital+11 more

Starling Oncology delivers cancer treatment and clinical research services through a network of clinics and employed clinicians in community settings across multiple states.

Digital HealthHealthtechMedical DevicesAlhambra, US

Daniel Virnich, M.D., MBA, FACHE(Chief Executive Officer)Yale D. Podnos, M.D., MPH, FACS(Chief Medical Officer, President of Practice)

Developing off-the-shelf hematopoietic stem cell therapies for severe diseases.

Co-investorsAIAisling CapitalNONorthpond Ventures

Suraksha operates a network of diagnostic and healthcare centres across eastern India offering pathology, genomics, radiology and imaging, and specialty clinics, along with home sample collection and doctor consultation services.

BiotechDigital HealthHealthtechMedical DevicesKolkata, IN

TandemAI combines AI-driven techniques with physics-based computational methods, backed by in-house high-performance computing and wet lab operations, to support drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechSaaS

Co-investorsF-F-Prime CapitalQIQiming Venture Partners

Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry.

BiotechDeep TechSouth San Francisco, US

Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)in

BoardMichael Goller(Director)RHReid Huber(Director)inPTPeter Thompson(Director)in

Co-investorsECEcoR1 CapitalRARA CapitalNONovo HoldingsOSOsage University PartnersTHThird Rock Ventures

The Oncology Institute is a cancer care provider offering treatment options, clinical trials, and research services across multiple locations for patients with various cancers, including lung and women's cancers.

Digital HealthHealthtech

Daniel Virnich(Chief Executive Officer)RCRob Carter(Chief Financial Officer)inYDYale D. Podnos(Chief Medical Officer, President of Practice)inJLJeffrey Langsam(Chief Clinical Officer)inJMJordan McInerney(Chief Development Officer)KEKristin England(Chief Administrative Officer)in

Co-investorsAEAea InvestorsHAHavencrest Capital Management

Theseus builds robotic situational awareness software using visual positioning for drones that operate in GPS-denied environments.

Advanced ManufacturingAI & Machine LearningDefense TechHardwareRoboticsSan Francisco, US

ILIan Laffey(Founder)inSLSacha Lévy(Founder)inCarl Schoeller(Founder)

Co-investorsY Y CombinatorFIFirst Round CapitalPIPioneerANAntlerENEndor CapitalFOForesite Capital+7 more

Co-investorsATAtlas VentureBABain Capital Life Sciences

TigerConnect provides a clinical communication and collaboration platform for hospitals and healthcare organizations, offering HIPAA-compliant messaging, scheduling, patient transfer, and AI-driven workflow tools.

AI & Machine LearningDigital HealthHealthtechSaaS

BBBrad Brooks(Founder)inABAndrew Brooks(Founder)inSOSean O'Neal(CEO)inTGTim Goodwin(Chief Technology Officer)inSHSheeza Hussain(Chief Growth Officer)inBKBrian Kaminski(Chief Customer Officer)in

Co-investorsVIVista Equity PartnersCOCorewell Health VenturesMOMontreux Equity PartnersNENew Science VenturesNONorwest Venture PartnersHEHealthQuest Capital+1 more

Topaz Therapeutics is developing a platform of next-generation oncology drugs.

BiotechHealthtech

TriSalus develops a therapeutic platform combining its Pressure-Enabled Drug Delivery (PEDD) method with immune-activating therapies to overcome intratumoral pressure and immunosuppression that limit treatment of liver and pancreatic tumors.

BiotechHealthtechMedical DevicesWestminster, US

SMSean Murphy(Executive Officer, Director)inJEJennifer E. Stevens(Executive Officer)inRichard B. Marshak(Executive Officer)inMSMary Szela(Executive Officer, Director)JDJodi Devlin(Executive Officer)inRobert H. Weiss(Chief Administrative Officer and Secretary)

Co-investorsTUTullis Health Investors

Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.

BiotechDigital HealthHealthtech

VPVishal Patelin

Co-investorsASAscenta CapitalATAtlas VentureBOBorealis VenturesBOBorealis VenturesMAMagnetic VenturesVIViking Global+4 more

TruNativ is a direct-to-consumer nutrition and wellness brand that makes food and supplement products using natural, whole-food ingredients without fillers, preservatives, or artificial additives.

ConsumerDirect to ConsumerWellness & Fitness

PMPranav Malhotra(Founder)in

Co-investorsRARainmatterVEVenture Catalysts | India's First Integrated Incubator

BiotechNew York, US

MBMichael Burgess(Executive Officer)Jose Manuel Otero(Executive Officer)Robert Gould(Director)inJHJane Henderson(Executive Officer)inStefan Larson(Director)Patrick Machado(Director)

Co-investorsBRBrace PharmaF-F-Prime CapitalFAFACIT (Fight Against Cancer Innovation Trust)FOFoothill VenturesVEVenture OntarioPOPoint72+1 more

TytoCare provides Home and Pro Smart Clinic solutions that let clinicians conduct clinical-grade remote physical exams using a handheld exam device combined with FDA-cleared AI decision support.

AI & Machine LearningDigital HealthMedical Devices

OTOfer Tzadik(Founder)inDGDedi Gilad(Founder)inAPAdam Pellegrini(Chief Executive Officer)inGOGreg Orr(Chief Operating Officer)inTGTamir Gotfried(Chief Business & Strategy Officer)inEBEyal Bychkov(VP Hardware & Innovation)in

Co-investorsECEcho Health VenturesINInsight PartnersLILionBirdMEMemorialCare Innovation FundOTOTVQUQualcomm Ventures+4 more

Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures.

HealthtechMedical DevicesPlymouth, US

Junfeng Wang(Director)David Perry(Executive Officer, Director)Tan Ching(Director)Hui Hu(Director, Promoter)Lixiao Wang(Director, Promoter)Doug Kohrs(Director)

Co-investorsHMHM Venture PartnersENEnterprise IrelandGIGilde HealthcareIRIreland Strategic Investment FundLELegend CapitalLILightstone Ventures+1 more

A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.

BiotechSan Diego, US

David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in

Co-investorsCHChiesi VenturesDEDecheng CapitalPAPappas CapitalSOSofinnova VenturesVEVedanta CapitalVIViking Global+4 more

Velsera provides integrated software and expert services that turn complex biomedical and genomic data into usable insights for precision medicine, drug discovery, diagnostics development, and genetic testing.

AI & Machine LearningBiotechDigital HealthHealthtech

JCJamie Coffin(Chief Executive Officer)inKSKareem Saad(President and Chief Business Officer)inPGPavel Gongora(Chief Strategy and Product Officer)inMKMike Kling(Chief Technology Officer)LCLou Clarke(Chief People Officer)inBZBecky Zimmerman(SVP Clinical Product and Chief Clinical Officer)in

Co-investorsHEHealth Catalyst CapitalSJSJF VenturesSUSumma Equity

Verdiva Bio is a biotechnology company focused on drug development.

BiotechHealthtech

JHJane Hughes(Chief Scientific Officer)inKFKhurem Farooq(Founder)in

Co-investorsRARA CapitalFOForbionGEGeneral Atlantic

vVARDIS develops biomimetic, non-invasive dental products based on P11-4 peptide technology to treat early-stage tooth decay by regenerating enamel without drilling.

BiotechHealthtechMedical DevicesBaar, CH

GOLNAR ABIVARDI-SIGNER(Director)HAHALEH ABIVARDI-BRONNER(Director)HAHaley Abivardi(Co-founder, DMD)inGAGoly Abivardi(Co-founder, DMD)in

BoardFLORIAN RANDLKOFER(Director)GERARDUS ADRIANUS HOOGLAND(Director)

Windward Bio is a clinical-stage biotechnology company developing long-acting monoclonal and bispecific antibodies for serious immunological conditions such as asthma, COPD, and dermatological diseases.

BiotechHealthtech

Co-investorsQUQuan CapitalRARA CapitalSASanofi VenturesSRSR One Capital ManagementJAJanus Henderson InvestorsNONovo Holdings+3 more

Yarrow Bioscience develops a first-in-class anti-TSHR antibody to treat thyroid autoimmune diseases, specifically Graves' disease and thyroid eye disease.

BiotechHealthtech

Zai is an Australian fintech payments provider that offers an integrated platform for processing multiple payment methods including credit cards, direct debits, and account-to-account transfers.

Enterprise SoftwareFintechSaaSMelbourne, AU

Co-investorsFRFrontline VenturesOCOctopus VenturesRARampersandREReinventure GroupSCSC VenturesCUCultivation Capital+2 more

Private clinical-stage biotech developing novel small molecule anti-tumoral agents in China.

Zylox-Tonbridge is a medical device company focused on neuro- and peripheral-vascular interventional solutions for healthcare professionals and patients.

HardwareHealthtechMedical Devices